First Financial Corp’s Endocyte, Inc. Common Stock ECYT Stock Holding History

First Financial Corp’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-100	Closed	-$2K	–	325
2018 Q3	$2K	Hold	100	–	–	﹤0.01%	325
2018 Q2	$1K	Hold	100	–	–	﹤0.01%	334
2018 Q1	$1K	Hold	100	–	–	﹤0.01%	339
2017 Q4	$0	Hold	100	–	–	﹤0.01%	384
2017 Q3	$0	Hold	100	–	–	﹤0.01%	391
2017 Q2	$0	Hold	100	–	–	﹤0.01%	410
2017 Q1	$0	Hold	100	–	–	﹤0.01%	430
2016 Q4	$0	Hold	100	–	–	﹤0.01%	420
2016 Q3	$0	Hold	100	–	–	﹤0.01%	444
2016 Q2	$0	Hold	100	–	–	﹤0.01%	480
2016 Q1	$0	Hold	100	–	–	﹤0.01%	453
2015 Q4	$0	Hold	100	–	–	﹤0.01%	463
2015 Q3	$0	Hold	100	–	–	﹤0.01%	489
2015 Q2	$1K	Hold	100	–	–	﹤0.01%	473
2015 Q1	$1K	Hold	100	–	–	﹤0.01%	463
2014 Q4	$1K	Hold	100	–	–	﹤0.01%	462
2014 Q3	$1K	Hold	100	–	–	﹤0.01%	476
2014 Q2	$1K	Buy	+100	New	+$1.13K	﹤0.01%	466

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

First Financial Corp's ECYT Position: Q4 2018 in Review

First Financial Corp sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 100 shares — an estimated $2K sold.

First Financial Corp first reported a position in ECYT in Q2 2014 and held it in 18 quarters. The position peaked at $2K in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

First Financial Corp reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
First Financial Corp sold 100 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $2K.
First Financial Corp first reported a position in Endocyte, Inc. Common Stock in Q2 2014 and held it in 18 quarters.
First Financial Corp's Endocyte, Inc. Common Stock position peaked at $2K in Q3 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on First Financial Corp's 13F filing for Q4 2018, filed 15 Jan 2019.